Skip to content

Music for Pain in Primary Dysmenorrhea

Music for the Management of Pain in Primary Dysmenorrhea in Students of the School of Medicine and Health Sciences From the Universidad Del Rosario

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03593850
Enrollment
649
Registered
2018-07-20
Start date
2017-09-01
Completion date
2018-04-17
Last updated
2024-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Menstrual, Primary Dysmenorrhea

Keywords

Pain management, Pain, Primary dysmenorrhea, Music, Music Therapy

Brief summary

Primary dysmenorrhea is defined as lower abdominal pain that occurs during menses and is not secondary to any type of pelvic disease. It is considered the most common condition in reproductive age women. First line of treatment are non-steroidal anti-inflammatory drugs (NSAIDS), or oral contraceptives (OCC). This two forms of treatment have not demonstrated 100% efficacy, and adverse events and contraindications for both exist. Moreover, studies have demonstrated that an important women do not use, or don't like to use, pharmacological treatment. Music have demonstrated analgesic effects in different clinical contexts, and has emerged as an important form of complementary therapy in the management of pain. To the researcher's knowledge, no studies have been conducted to evaluate music's effectiveness in pain secondary to primary dysmenorrhea. The following is the protocol for a randomized, single blinded, clinical trial, where an experimental group listened to a 30 minute song, and was compared to a control group that rest in silence for the same time and conditions. It was expected that music will produce a larger, and significant, effect on pain reduction when compared to the control silence group according to pain measured through a 10 cm Visual Analogue Scale (VAS) in young women from the School of Medicine and Health Sciences at the Universidad del Rosario, Bogota DC, Colombia. Additionally, the investigators wanted to evaluate the clinical effect of music and analgesic requirements, anxiety and vital signs were also measured.

Detailed description

Primary Dysmenorrhea (PD) is defined as pain in the lower abdomen, that occurs always during menses, in the absence of pelvic pathology, and lasts about 24-72 hours. It initiates during the first 24 months after menarche. Other symptoms like, emotional lability, anxiety, nausea, headache, and others may accompany the pain. It is considered the most common condition of reproductive age women, and is considered one of the most important causes for school or work absence in this population. Music has been proposed as a complementary therapy for the management of pain, and a large body of clinical evidence supports its use on clinical context. Additionally, functional imaging research has found that music activates areas related to pain modulation and perception like the periaqueductal gray matter. Moreover music seems to modify brain activity during pain perception. Music has been shown to be effective in relieving pain secondary to surgery, in cancer related pain, and other types of pain, but it has not been studied for primary dysmenorrhea. This randomized clinical trial was designed with the following objectives General Objective: To evaluate the efficacy of music listening, compared to a control group that rested in silence, in the painful experience secondary to primary dysmenorrhea in women of 18 years or older from the School of Medicine and Health Sciences at the Universidad del Rosario, Bogotá DC., Colombia. Specific Objectives: 1. Description of demographic data, clinical, gynecological, and obstetric background from the study population. 2. Description of pain management, secondary to PD, used by the study population. 3. Evaluate the usual pain secondary to PD, as reported by the study participants through a Visual Analogue Scale (VAS) 4. To explore if the acute perception of pain secondary to PD, as reported by participants using a VAS, before the intervention, is different between the study groups. 5. To evaluate if the acute perception of pain secondary to PD, as reported by participants using a VAS, after the intervention, differs between those that listened to music and those that rested in silence. 6. To explore if a difference in the reduction of pain, as reported by participants using a VAS, from the moment before to the moment after the intervention exists between those in the music group compared to those in the silence group. 7. To evaluate if the acute perception of pain secondary to PD, as reported by participants using a VAS, 3-6 hours after the intervention, differs between those that listened to music and those that rested in silence. 8. To evaluate if the anxiety secondary to PD, as reported by participants using a validated Spanish short version of the Zung scale, differs between groups, before and after the intervention. 9. To evaluate if a difference in the reported requirements of analgesic drugs is different between the study groups after and 3-6 hours after the intervention. 10. To evaluate if a difference in heart rate, systolic and diastolic blood pressure is identified between groups, using a previously calibrated digital sphyngmomanometer. The investigators hypothesized that listening to an instrumental song, unknown to the patient, will have a significant effect on pain relief. Additionally, investigators hypothesized that music listening will have a clinical effect big enough to also impact analgesic requirements and anxiety scores . Primary endpoint was pain reduction from the moment before to after the intervention. Pain reduction is the better way to evaluate analgesia efficacy and was the proper approach for these protocol's main objective, which was efficacy of music on pain relief secondary to primary dysmenorrhea. For achieving these aims and answering research questions, a randomized clinical trial was designed. As patients can't be blinded from listening or not to music, a single blinded approach was decided. Furthermore, methodology for recruitment was designed to blind patients from allocation until the day of the intervention and a speech was used to avoid patients to identify the primary endpoint. Additionally, patients were explained that two interventions were used, but it was not specified that silence group was the control group, to assure proper blinding and avoid further bias of results. Silence was decided as a control intervention as comparison with drug placebo may not be adequate due to differences in the types of intervention. To isolate the music effects the investigators decided on using a completely new and unknown song. The song was planned and composed exclusively for the research, so all patients allocated to the music group listened to the exact same musical piece.

Interventions

BEHAVIORALMusic group

The song was composed on a C major scale and a 60 bpm tempo. The song was composed with high consonance using simple melodic progressions on the C major scale, and using natural positions for chords. No percussion or lyrics were used for the song, and the following instruments were used in the composition: electric guitar and keyboards, violin (digital), cello (digital), clarinet (digital), synthesizers (digital), and fretless bass (digital).

BEHAVIORALSilence Group

Audio file that contained no sounds.

Sponsors

Universidad del Rosario
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Masking description

Computer block randomization was used to generate allocation sequence of codes. Allocation was done on the same day of the intervention, patients were given opaque envelope according to the randomization codes. The envelop contained instructions to access the allocated intervention. After baseline data collection patients entered the intervention room and opened the envelop inside while investigator waited outside. Both patients had headphones on and used the same device to access the intervention assuring blinding of the investigator. After the intervention ended, patient closed the intervention file and account to the intervention. All patients were instructed to nor reveal or comment anything about the intervention at any time after the intervention was completed.

Intervention model description

Single blinded, two parallel group, randomized clinical trial. The experimental group received listen to a son composed exclusively for this trial while control group rested for the same amount of time in silence.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Legal and cognitive capacity for informed consent. * Suffering from primary dysmenorrhea (low abdominal pain associated to menses). * Being able to understand and use the measuring tools and questionnaires.

Exclusion criteria

* Previous diagnosis of pelvic pathology. * Diagnosis of hearing impairment. * Diagnosis of neurologic or endocrinological disease. * Psychiatric condition diagnosed. * Known or reported previous substance abuse. * Current use of psychiatric drugs. * Cancer diagnosis * Diagnosed diabetes mellitus or heart disease. * Previous advance musical training (defined as any form of music training in addition to that received during normal school classes). * Irregular menstrual cycles. * Previous pregnancy. * Current use or use of any hormonal contraceptive therapy in the last 2 months.

Design outcomes

Primary

MeasureTime frameDescription
Change in Pain From 1-5 Minutes Before (Baseline) to 1- 5 Minutes After the InterventionFrom 1-5 minutes before the intervention (baseline) to 1-5 minutes after the intervention.Pain scores were measured using a visual analogue scale (VAS) of 10 cm (0 no pain at all, and 10 the worst possible pain) at each time point. Main outcome was calculated from the difference between visual analogue score at 1-5 minutes after (VAS3) minus visual analogue score at 1-5 minutes before the intervention (VAS2).

Secondary

MeasureTime frameDescription
Actual Pain 1-5 Minutes Before the Intervention (Baseline).1-5 minutes before the intervention.Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Actual pain was evaluated immediately before the intervention and was known as VAS 2.
Actual Pain 1-5 Minutes After the Intervention.1-5 minutes after the intervention.Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Actual pain was evaluated immediately after the intervention was completed, and was known as VAS 3.
Actual Pain 3-6 Hours After the Intervention.3-6 hours after the intervention.Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Actual pain was evaluated 3-6 hours after the intervention was completed, and was known as VAS 4.
Anxiety Score Before the Intervention1-5 minutes before the intervention.Using a validated short spanish version of the Zung anxiety scale, anxiety was measured before the intervention. The scale was composed of 10 items. Each item had a 4 Likert point scale (0= never, 1= some times, 2= most of the time, and 3 = always). Final scores ranged from 0, minimum anxiety, and 30 maximum anxiety.
Systolic Blood Pressure After the Intervention1-5 minutes after the intervention.Systolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer after the intervention.
Diastolic Blood Pressure After the Intervention1-5 minutes after the intervention.Diastolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer after the intervention.
Anxiety Score After the Intervention1-5 minutes after the intervention.Using a validated short spanish version of the Zung anxiety scale, anxiety was measured after the intervention. The scale was composed of 10 items. Each item had a 4 Likert point scale (1= never, 2= some times, 3= most of the time, and 4 = always). Scores ranged from 10, minimum anxiety, and 40 maximum anxiety. For analysis, mean quantitative scores were obtained so 1 was equivalent to minimum anxiety, and 4 to maximum anxiety.
Anxiety Score 3-6 Hours After the Intervention3-6 hours after fter the intervention.Using a validated short spanish version of the Zung anxiety scale, anxiety was measured 3-6 hours after the intervention. The scale was composed of 10 items. Each item had a 4 Likert point scale (0= never, 1= some times, 2= most of the time, and 3= always). Scores ranged from 0, minimum anxiety, and 30 maximum anxiety.
Usual Pain Associated to Menses5-10 minutes before the intervention.Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Usual pain was evaluated before the intervention and was known as VAS 1.
Analgesic Requirements After1-5 minutes after the intervention.After the intervention patients were asked if they wanted to use any analgesic drug or do any kind of analgesic strategy. Patients simply answered yes or no.
Analgesic Use During a Period of 3-6 Hours After the Intervention.3-6 hours after the intervention)After the intervention, all patients had to register all analgesic drugs (e.g. ibuprofen) or strategy (e.g. local heat) that were used until last pain measurement (VAS 4, 3-6 hours after the intervention).
Systolic Blood Pressure Before the Intervention1-5 minutes before the intervention.Systolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer before the intervention.
Diastolic Blood Pressure Before the Intervention1-5 minutes before the intervention.Diastolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer before the intervention.
Heart Rate Before the Intervention1-5 minutes before the intervention.Heart rate measured in beats per minute (bpm) with a calibrated digital sphygmomanometer before the intervention.
Mean Blood Pressure Before the Intervention1-5 minutes before the intervention.Mean blood pressure in mmHg measured with a calibrated digital sphygmomanometer before the intervention.
Heart Rate After the Intervention1-5 minutes after the intervention.Heart rate in beats per minute (bpm) measured with a calibrated digital sphygmomanometer after the intervention.
Mean Blood Pressure After the Intervention1-5 minutes after the intervention.Mean blood pressure in mmHg measured with a calibrated digital sphygmomanometer after the intervention.
Analgesic Requirements Before1-5 minutes before the intervention the intervention.Before the intervention patients were asked if they wanted to use any analgesic drug or do any kind of analgesic strategy. Patients simply answered yes or no.

Countries

Colombia

Participant flow

Recruitment details

Patients were recruited and between September 2017 to April 2018 from the School of Medicine and Health Sciences, and the School of Mathematics and Natural Sciences from Universidad del Rosario. Assessment, data collection, and intervention occurred within the facilities of the School of Medicine and Health Sciences from Universidad del Rosario, Bogota D.C., Colombia.

Pre-assignment details

A total of 597 participants were excluded: 470 did not met inclusion criteria, 98 declined to participate, and 29 signed consent but never came for randomization and the intervention.

Participants by arm

ArmCount
Music Group
Patients in this arm listened through headphones to a song of 29 minutes and 32 seconds duration. The song was composed entirely by investigator Juan Martin-Saavedra and registered to copyright and authorship regulatory entities from Colombia under the name Occasio adolore (Musical piece No. 5-559-355 and Phonogram No. 12-105-295 of Colombia's Copyright authorship agency). Patients were instructed to avoid using cellphones or other activities during the time of the intervention. Patients receive the intervention in the same room as the Silence group, but for the intervention they were always alone. The room was located in a low transit place with low ambient noise. Music group: The song was composed on a C major scale and a 60 bpm tempo. The song was composed with high consonance using simple melodic progressions on the C major scale, and using natural positions for chords. No percussion or lyrics were used for the song, and the following instruments were used in the composition: electric guitar and keyboards, violin (digital), cello (digital), clarinet (digital), synthesizers (digital), and fretless bass (digital).
29
Silence Group
Patients on the silence group listened to a 29 minute and 32 second audio file that produced no sounds with headphones on. Patients were instructed to avoid using cellphones or other activities during the time of the intervention. Patients receive the intervention in the same room as the Music group, but for the intervention they were always alone. The room was located in a low transit place with low ambient noise. Silence Group: Audio file that contained no sounds.
23
Total52

Withdrawals & dropouts

PeriodReasonFG000FG001
3-6 Hours Post Intervention OutcomesDid not returned or filled wrongly the outcome questionnaire23

Baseline characteristics

CharacteristicTotalMusic GroupSilence Group
Academic semester
First to Fifth
36 Participants21 Participants15 Participants
Academic semester
Sixth to Tenth
16 Participants8 Participants8 Participants
Age at menarche12.15 years
STANDARD_DEVIATION 1.33
12.14 years
STANDARD_DEVIATION 1.51
12.17 years
STANDARD_DEVIATION 1.11
Age, Continuous19.87 years
STANDARD_DEVIATION 1.91
20.1 years
STANDARD_DEVIATION 2.27
19.57 years
STANDARD_DEVIATION 1.31
Analgesia 1
No
29 Participants17 Participants12 Participants
Analgesia 1
Yes
23 Participants12 Participants11 Participants
Analgesic used on last menstrual period
No
23 Participants17 Participants6 Participants
Analgesic used on last menstrual period
Yes
29 Participants12 Participants17 Participants
Anxiety (A1) - Abbreviated Zung anxiety scale1.86 units on a scale
STANDARD_DEVIATION 0.38
1.8 units on a scale
STANDARD_DEVIATION 0.37
1.9 units on a scale
STANDARD_DEVIATION 0.44
Diastolic blood pressure69.82 mmHg
STANDARD_DEVIATION 10.41
71.1 mmHg
STANDARD_DEVIATION 10.79
68.14 mmHg
STANDARD_DEVIATION 9.88
Duration of menses5.11 days
STANDARD_DEVIATION 1.29
5.03 days
STANDARD_DEVIATION 1.32
5.22 days
STANDARD_DEVIATION 1.28
First ever menstrual pain
1-2 years after menarche
21 Participants14 Participants7 Participants
First ever menstrual pain
1-6 months after menarche
10 Participants2 Participants8 Participants
First ever menstrual pain
6-12 months after menarche
4 Participants3 Participants1 Participants
First ever menstrual pain
At the time of menarche
15 Participants9 Participants6 Participants
First ever menstrual pain
Other
2 Participants1 Participants1 Participants
Heart rate75.62 bpm
STANDARD_DEVIATION 12.16
75.48 bpm
STANDARD_DEVIATION 12.56
75.68 bpm
STANDARD_DEVIATION 11.87
History of surgeries in their lifetime
No
37 Participants20 Participants17 Participants
History of surgeries in their lifetime
Yes
15 Participants9 Participants6 Participants
Hours with pain6.15 hours
STANDARD_DEVIATION 5.44
6.27 hours
STANDARD_DEVIATION 5.84
6 hours
STANDARD_DEVIATION 5.04
Intermenstrual time29.1 days
STANDARD_DEVIATION 2.23
29.07 days
STANDARD_DEVIATION 2.59
29.13 days
STANDARD_DEVIATION 1.74
Mean arterial blood pressure82.39 mmHg
STANDARD_DEVIATION 9.96
83.83 mmHg
STANDARD_DEVIATION 10.32
80.62 mmHg
STANDARD_DEVIATION 9.31
Menstrual pain duration
10-24 hours
18 Participants11 Participants7 Participants
Menstrual pain duration
24-48 hours
15 Participants9 Participants6 Participants
Menstrual pain duration
48-72 hours
5 Participants3 Participants2 Participants
Menstrual pain duration
Less than 10 hours
12 Participants5 Participants7 Participants
Menstrual pain duration
Other
2 Participants1 Participants1 Participants
Menstrual pain onset
24 hours after
13 Participants8 Participants5 Participants
Menstrual pain onset
48-24 hours before
7 Participants1 Participants6 Participants
Menstrual pain onset
Less than 24 hours before
9 Participants3 Participants6 Participants
Menstrual pain onset
Other
3 Participants3 Participants0 Participants
Menstrual pain onset
Same day
20 Participants14 Participants6 Participants
Non-pharmacologic treatment used in last menstrual period
No
31 Participants19 Participants12 Participants
Non-pharmacologic treatment used in last menstrual period
Yes
21 Participants10 Participants11 Participants
Pain pre-intervention - Visual Analogue Scale (VAS2)4.887 units on a scale
STANDARD_DEVIATION 2.205
4.82 units on a scale
STANDARD_DEVIATION 2.04
4.97 units on a scale
STANDARD_DEVIATION 1.9
Presence of comorbidities
No
45 Participants25 Participants20 Participants
Presence of comorbidities
Yes
7 Participants4 Participants3 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Colombia
52 participants29 participants23 participants
Sex: Female, Male
Female
52 Participants29 Participants23 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Systolic blood pressure107.51 mmHg
STANDARD_DEVIATION 11.56
108.97 mmHg
STANDARD_DEVIATION 11.98
105.59 mmHg
STANDARD_DEVIATION 10.97
Type of menstrual pain
Colic-like
30 Participants18 Participants12 Participants
Type of menstrual pain
Mixed
9 Participants5 Participants4 Participants
Type of menstrual pain
Oppressive-like
13 Participants6 Participants7 Participants
University program
Medicine
16 Participants6 Participants10 Participants
University program
Other (Epidemiology, Gynecology, Biology)
5 Participants5 Participants0 Participants
University program
Phonoaudiology
12 Participants5 Participants7 Participants
University program
Physiotherapy
12 Participants8 Participants4 Participants
University program
Psychology
7 Participants5 Participants2 Participants
Usual menstrual pain - Visual Analogue Scale (VAS1)6.549 units on a scale
STANDARD_DEVIATION 1.71
6.34 units on a scale
STANDARD_DEVIATION 1.69
6.76 units on a scale
STANDARD_DEVIATION 1.77

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 290 / 23
other
Total, other adverse events
0 / 290 / 23
serious
Total, serious adverse events
0 / 290 / 23

Outcome results

Primary

Change in Pain From 1-5 Minutes Before (Baseline) to 1- 5 Minutes After the Intervention

Pain scores were measured using a visual analogue scale (VAS) of 10 cm (0 no pain at all, and 10 the worst possible pain) at each time point. Main outcome was calculated from the difference between visual analogue score at 1-5 minutes after (VAS3) minus visual analogue score at 1-5 minutes before the intervention (VAS2).

Time frame: From 1-5 minutes before the intervention (baseline) to 1-5 minutes after the intervention.

Population: Intention to treat analysis used

ArmMeasureValue (MEAN)Dispersion
Music GroupChange in Pain From 1-5 Minutes Before (Baseline) to 1- 5 Minutes After the Intervention-1.85 cmStandard Deviation 1.78
Silence GroupChange in Pain From 1-5 Minutes Before (Baseline) to 1- 5 Minutes After the Intervention-0.18 cmStandard Deviation 1.8
p-value: 0.002t-test, 2 sided
Secondary

Actual Pain 1-5 Minutes After the Intervention.

Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Actual pain was evaluated immediately after the intervention was completed, and was known as VAS 3.

Time frame: 1-5 minutes after the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupActual Pain 1-5 Minutes After the Intervention.2.97 units on a scaleStandard Deviation 2.15
Silence GroupActual Pain 1-5 Minutes After the Intervention.4.77 units on a scaleStandard Deviation 2.68
p-value: 0.01t-test, 2 sided
p-value: 0.006ANCOVA
Secondary

Actual Pain 1-5 Minutes Before the Intervention (Baseline).

Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Actual pain was evaluated immediately before the intervention and was known as VAS 2.

Time frame: 1-5 minutes before the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupActual Pain 1-5 Minutes Before the Intervention (Baseline).4.82 cmStandard Deviation 2.04
Silence GroupActual Pain 1-5 Minutes Before the Intervention (Baseline).4.97 cmStandard Deviation 2.44
p-value: 0.802t-test, 2 sided
Secondary

Actual Pain 3-6 Hours After the Intervention.

Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Actual pain was evaluated 3-6 hours after the intervention was completed, and was known as VAS 4.

Time frame: 3-6 hours after the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupActual Pain 3-6 Hours After the Intervention.2.37 units on a scaleStandard Deviation 2.31
Silence GroupActual Pain 3-6 Hours After the Intervention.3.63 units on a scaleStandard Deviation 2.83
p-value: 0.11t-test, 2 sided
p-value: 0.37ANCOVA
Secondary

Analgesic Requirements After

After the intervention patients were asked if they wanted to use any analgesic drug or do any kind of analgesic strategy. Patients simply answered yes or no.

Time frame: 1-5 minutes after the intervention.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Music GroupAnalgesic Requirements AfterYes4 Participants
Music GroupAnalgesic Requirements AfterNo25 Participants
Silence GroupAnalgesic Requirements AfterYes10 Participants
Silence GroupAnalgesic Requirements AfterNo13 Participants
p-value: 0.02Chi-squared
Secondary

Analgesic Requirements Before

Before the intervention patients were asked if they wanted to use any analgesic drug or do any kind of analgesic strategy. Patients simply answered yes or no.

Time frame: 1-5 minutes before the intervention the intervention.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Music GroupAnalgesic Requirements BeforeYes12 Participants
Music GroupAnalgesic Requirements BeforeNo17 Participants
Silence GroupAnalgesic Requirements BeforeYes11 Participants
Silence GroupAnalgesic Requirements BeforeNo12 Participants
p-value: 0.642Chi-squared
Secondary

Analgesic Use During a Period of 3-6 Hours After the Intervention.

After the intervention, all patients had to register all analgesic drugs (e.g. ibuprofen) or strategy (e.g. local heat) that were used until last pain measurement (VAS 4, 3-6 hours after the intervention).

Time frame: 3-6 hours after the intervention)

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Music GroupAnalgesic Use During a Period of 3-6 Hours After the Intervention.Yes6 Participants
Music GroupAnalgesic Use During a Period of 3-6 Hours After the Intervention.No21 Participants
Silence GroupAnalgesic Use During a Period of 3-6 Hours After the Intervention.Yes11 Participants
Silence GroupAnalgesic Use During a Period of 3-6 Hours After the Intervention.No8 Participants
p-value: 0.025Chi-squared
Secondary

Anxiety Score 3-6 Hours After the Intervention

Using a validated short spanish version of the Zung anxiety scale, anxiety was measured 3-6 hours after the intervention. The scale was composed of 10 items. Each item had a 4 Likert point scale (0= never, 1= some times, 2= most of the time, and 3= always). Scores ranged from 0, minimum anxiety, and 30 maximum anxiety.

Time frame: 3-6 hours after fter the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupAnxiety Score 3-6 Hours After the Intervention1.49 score on a scaleStandard Deviation 0.29
Silence GroupAnxiety Score 3-6 Hours After the Intervention1.62 score on a scaleStandard Deviation 0.36
p-value: 0.168t-test, 2 sided
Secondary

Anxiety Score After the Intervention

Using a validated short spanish version of the Zung anxiety scale, anxiety was measured after the intervention. The scale was composed of 10 items. Each item had a 4 Likert point scale (1= never, 2= some times, 3= most of the time, and 4 = always). Scores ranged from 10, minimum anxiety, and 40 maximum anxiety. For analysis, mean quantitative scores were obtained so 1 was equivalent to minimum anxiety, and 4 to maximum anxiety.

Time frame: 1-5 minutes after the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupAnxiety Score After the Intervention1.53 score on a scaleStandard Deviation 0.33
Silence GroupAnxiety Score After the Intervention1.73 score on a scaleStandard Deviation 0.38
p-value: 0.049t-test, 2 sided
Secondary

Anxiety Score Before the Intervention

Using a validated short spanish version of the Zung anxiety scale, anxiety was measured before the intervention. The scale was composed of 10 items. Each item had a 4 Likert point scale (0= never, 1= some times, 2= most of the time, and 3 = always). Final scores ranged from 0, minimum anxiety, and 30 maximum anxiety.

Time frame: 1-5 minutes before the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupAnxiety Score Before the Intervention1.8 score on a scaleStandard Deviation 0.37
Silence GroupAnxiety Score Before the Intervention1.9 score on a scaleStandard Deviation 0.44
p-value: 0.377t-test, 2 sided
Secondary

Diastolic Blood Pressure After the Intervention

Diastolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer after the intervention.

Time frame: 1-5 minutes after the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupDiastolic Blood Pressure After the Intervention69.9 mmHgStandard Deviation 9.39
Silence GroupDiastolic Blood Pressure After the Intervention65.26 mmHgStandard Deviation 7.19
p-value: 0.056t-test, 2 sided
Secondary

Diastolic Blood Pressure Before the Intervention

Diastolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer before the intervention.

Time frame: 1-5 minutes before the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupDiastolic Blood Pressure Before the Intervention71.1 mmHgStandard Deviation 10.79
Silence GroupDiastolic Blood Pressure Before the Intervention68.14 mmHgStandard Deviation 9.88
p-value: 0.318t-test, 2 sided
Secondary

Heart Rate After the Intervention

Heart rate in beats per minute (bpm) measured with a calibrated digital sphygmomanometer after the intervention.

Time frame: 1-5 minutes after the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupHeart Rate After the Intervention74.48 bpmStandard Deviation 11.22
Silence GroupHeart Rate After the Intervention74.96 bpmStandard Deviation 12.32
p-value: 0.885t-test, 2 sided
Secondary

Heart Rate Before the Intervention

Heart rate measured in beats per minute (bpm) with a calibrated digital sphygmomanometer before the intervention.

Time frame: 1-5 minutes before the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupHeart Rate Before the Intervention75.48 bpmStandard Deviation 12.56
Silence GroupHeart Rate Before the Intervention75.68 bpmStandard Deviation 11.87
p-value: 0.954t-test, 2 sided
Secondary

Mean Blood Pressure After the Intervention

Mean blood pressure in mmHg measured with a calibrated digital sphygmomanometer after the intervention.

Time frame: 1-5 minutes after the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupMean Blood Pressure After the Intervention83.04 mmHgStandard Deviation 10.22
Silence GroupMean Blood Pressure After the Intervention77.92 mmHgStandard Deviation 6.77
p-value: 0.036t-test, 2 sided
Secondary

Mean Blood Pressure Before the Intervention

Mean blood pressure in mmHg measured with a calibrated digital sphygmomanometer before the intervention.

Time frame: 1-5 minutes before the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupMean Blood Pressure Before the Intervention83.83 mmHgStandard Deviation 10.32
Silence GroupMean Blood Pressure Before the Intervention80.62 mmHgStandard Deviation 75.68
p-value: 0.258t-test, 2 sided
Secondary

Systolic Blood Pressure After the Intervention

Systolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer after the intervention.

Time frame: 1-5 minutes after the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupSystolic Blood Pressure After the Intervention109.66 mmHgStandard Deviation 14.04
Silence GroupSystolic Blood Pressure After the Intervention103.26 mmHgStandard Deviation 9.66
p-value: 0.058t-test, 2 sided
Secondary

Systolic Blood Pressure Before the Intervention

Systolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer before the intervention.

Time frame: 1-5 minutes before the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupSystolic Blood Pressure Before the Intervention108.97 mmHgStandard Deviation 11.98
Silence GroupSystolic Blood Pressure Before the Intervention105.59 mmHgStandard Deviation 10.97
p-value: 0.307t-test, 2 sided
Secondary

Usual Pain Associated to Menses

Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Usual pain was evaluated before the intervention and was known as VAS 1.

Time frame: 5-10 minutes before the intervention.

ArmMeasureValue (MEAN)Dispersion
Music GroupUsual Pain Associated to Menses6.34 cmStandard Deviation 1.69
Silence GroupUsual Pain Associated to Menses6.76 cmStandard Deviation 1.77
p-value: 0.392t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026